Atrimed Pharmaceuticals Private Limited - Company Profile

It is a healthcare private limited company based in Bangalore, Karnataka, India, established in 2003.
2003 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Atrimed Pharmaceuticals Private Limited

Atrimed Pharmaceuticals Private Limited, a active private limited company, was established on 03 July 2003 in Bangalore, Karnataka, India. Engaging in ayurvedic products & services within the hospital and medical care sector, it holds CIN: U02423KA2003PTC032200. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹8.50 Cr and a paid-up capital of ₹8.16 Cr.

Formerly known as Atrimed Herbals Private Limited. It upholds a compliant status. Employing 132 professional, Its leadership includes Ganju Shibban Krishen (Director), Hrishikesh Damle (Director), Rishi Ganju (Director). Past directors included Rashmi P G, Sanjay Raj, Rishi Ganju. It holds ₹2.41 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.755, 3Rd Cross,11Th Block, 2Nd Stage, Bda Layout, Nagarbhavi Bangalore, Bangalore, Karnataka, 560072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U02423KA2003PTC032200

  • Registration Number

    032200

  • Incorporation Date

    03 July 2003

  • Authorized Capital

    ₹8.50 Cr

  • Paid-Up Capital

    ₹8.16 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.50 Cr
  • Paid Up Capital ₹ 8.16 Cr
  • Company Age 22 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.41 Cr
  • Revenue Growth **** 44.96%
  • Profit Growth **** 197.83%
  • Ebitda **** 12090.12%
  • Net Worth 33.47%
  • Total Assets **** 18.14%
Company report

Atrimed Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Atrimed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Atrimed Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ganju Shibban Krishen Director 25 Mar 2010 Current
Hrishikesh Damle Director 03 Jul 2003 Current
Rishi Ganju Director 09 Sep 2021 Current
Latha Damle Director 09 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 25 Sep 2018 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Atrimed Pharmaceuticals.

Atrimed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.96% increase. The company also saw a substantial improvement in profitability, with a 197.83% increase in profit. The company's net worth Soared by an impressive increase of 33.47%.

Atrimed Pharmaceuticals revenue growth over time
Atrimed Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 44.96%
*******
*******
*******
*******
Revenue from Operations
*******
 48.98%
*******
*******
*******
*******
Total Assets
*******
 18.14%
*******
*******
*******
*******
Profit or Loss
*******
 197.83%
*******
*******
*******
*******
Net Worth
*******
 33.47%
*******
*******
*******
*******
EBITDA
*******
 12090.12%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Atrimed Pharmaceuticals?

In 2021, Atrimed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹24,107,998.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
  • Hdfc Bank Limited : 0.41 Cr
Latest Charge Details
Date Lender Amount Status
18 Oct 2024 Others ₹2.00 Cr Open
31 Oct 2022 Hdfc Bank Limited ₹4.11 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Atrimed Pharmaceuticals?

Atrimed Pharmaceuticals has a workforce of 132 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Atrimed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atrimed Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Atrimed Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101001513 was registered on 18 Oct 2024. was recorded as a recent event.

  • Annual General Meeting

    The activity Atrimed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Atrimed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.41 Cr with Charge ID 100666262 was registered on 31 Oct 2022. was completed.

  • Director Appointment

    The activity Rishi Ganju was appointed as a Director was appointed as a Director on 09 Sep 2021 & has been associated with this company since 4 years 5 months . was completed.

  • Director Appointment

    Latha Damle was appointed as a Director was appointed as a Director on 09 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Atrimed Pharmaceuticals Private Limited?

The CIN of Atrimed Pharmaceuticals Private Limited is U02423KA2003PTC032200.

Where is Atrimed Pharmaceuticals Private Limited headquartered?

Atrimed Pharmaceuticals Private Limited is headquartered at No.755, 3Rd Cross,11Th Block, 2Nd Stage, Bda Layout, Nagarbhavi Bangalore, Bangalore, Karnataka, 560072.

When was Atrimed Pharmaceuticals Private Limited incorporated?

Atrimed Pharmaceuticals Private Limited was incorporated on 03 July 2003.

Who are the current directors of Atrimed Pharmaceuticals Private Limited?

The current directors of Atrimed Pharmaceuticals Private Limited are

What is the primary industry of Atrimed Pharmaceuticals Private Limited?

The primary industry of Atrimed Pharmaceuticals Private Limited is Hospital And Medical Care.

Is Atrimed Pharmaceuticals Private Limited a listed company?

Atrimed Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Atrimed Pharmaceuticals Private Limited?

The authorized capital of Atrimed Pharmaceuticals Private Limited is ₹8.50 Cr, and the paid-up capital is ₹8.16 Cr.

What is the compliance status of Atrimed Pharmaceuticals Private Limited?

The compliance status of Atrimed Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available